Mitral regurgitation

Swiss Medical Weekly

Volumn 140, Issue 3-4, 2010, Pages 36-43

  Pedrazzini, Giovanni B ^a   Faletra, Francesco F ^a   Vassalli, Giuseppe ^a   Demertzis, Stefanos ^a   Moccetti, Tiziano ^a  

^a DIVISION OF CARDIOLOGY   (Switzerland)

Author keywords

Heart failure; Mitral leaflets; Mitral regurgitation; Mitral valve; Mitral valve repair; Mitral valve replacement

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; NITROPRUSSIDE SODIUM; SPIRONOLACTONE;

ANTICOAGULANT THERAPY; AORTA VALVE STENOSIS; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CONTROLLED STUDY; DEVELOPING COUNTRY; DISEASE COURSE; DISEASE SEVERITY; ECHOCARDIOGRAPHY; HEART FAILURE; HEART VALVE REPLACEMENT; HUMAN; ISCHEMIC HEART DISEASE; MITRAL VALVE REGURGITATION; MITRAL VALVE REPAIR; MITRAL VALVE REPLACEMENT; MULTICENTER STUDY; PATHOLOGICAL ANATOMY; PROGNOSIS; REVIEW; RHEUMATIC HEART DISEASE; VALVULOPLASTY;

EID: 75849151505     PISSN: 14247860     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (38)

1. Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M. Burden of valvular heart diseases: a population-based study. Lancet. 2006;368:1005-11.
2. Iung B, Baron G, Butchart EG, et al. A prospective survey of patients with valvular heart disease in Europe: the Euro heart survey on valvular heart disease. Eur Heart J. 2003;24:1231-43.
3. Enriquez-Sarano M, Akins CW, Vahanian A. Mitral regurgitation. Lancet. 2009;373:1382-94.
4. DiGregorio V, Zehr KJ, Orszulak TA, et al. Results of mitral surgery in octogenarians with isolated nonrheumatic mitral regurgitation. Ann Thorac Surg. 2004;78:807-13.
5. Feldman T. Percutaneous mitral valve repair. J Interv Cardiol. 2007;20:488-94.
6. Kunzelman KS, Cochran RP. Mechanical properties of basal and marginal mitral valve chordae tendineae. ASAIO Trans. 1990;36:M405-M408.
7. Messas E, Yosefy C, Chaput M, et al. Chordal cutting does not adversely affect left ventricle contractile function. Circulation. 2006;114:I-524-I-528.
8. Zoghbi WA, Enriquez-Sarano M, Foster E, et al. Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr. 2003;16:777-802.
9. Enriquez-Sarano M, Tribouilloy C. Quantitation of mitral regurgitation: rationale, approach, and interpretation in clinical practice. Heart. 2002;88(Suppl. 4):iv1-3.
10. Enriquez-Sarano M, Basmadjian A, Rossi A, Bailey K, Seward J, Tajik A. Progression of mitral regurgitation: a prospective Doppler echocardiographic study. J Am Coll Cardiol. 1999;34:1137-44.
11. Rosen SE, Borer JS, Hochreiter C, et al. Natural history of the asymptomatic/minimally symptomatic patient with severe mitral regurgitation secondary to mitral valve prolapse and normal right and left ventricular performance. Am J Cardiol. 1994;74:374-80.
12. Enriquez-Sarano M, Freeman WK, Tribouilloy CM, et al. Functional anatomy of mitral regurgitation: accuracy and outcome implications of transesophageal echocardiography. J Am Coll Cardiol. 1999;34:1129-36.
13. Enriquez-Sarano M, Avierinos JF, Messika-Zeitoun D, et al. Quantitative determinants of the outcome of asymptomatic mitral regurgitation N Engl J Med. 2005;352:875-33.
14. Vahanian A, Baumgartner H, Bax J, et al. Guidelines on the management of valvular heart disease: the Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology Eur Heart J. 2007;28:230-68.
15. Carabello BA. The current therapy for mitral regurgitation. J Am Coll Cardiol. 2008;52:319-26.
16. Nishimura, RA, Carabello BA, Faxon DP, et al. ACC/AHA 2008 Guideline Update on Valvular Heart Disease: Focused Update on Infective Endocarditis. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation. 2008;118:887-96.
17. Shuhaiber J, Anderson RJ. Meta-analysis of clinical outcomes following surgical mitral valve repair or replacement. Eur J Cardiothorac Surg. 2007;31:267-75.
18. Morimoto H, Tsuchiya K, Nakajima M, Akashi O. Mitral valve repair for anterior leaflet prolapse: surgical techniques review and 16-year follow-up results. J Card Surg. 2008;23:426-30.
19. Suri RM, Scahff HV, Dearanu JA, et al. Recovery of left ventricular function after surgical correction of mitral regurgitation caused by leaflet prolapse. J Thorac Cardiovasc Surg. 2009;137:1071-6.
20. Votta E, Maisano F, Bolling SF, Alfieri O, Montevecchi FM, Redaelli A. The Geoform disease-specific annuloplasty system: a finite element study. Ann Thorac Surg. 2007;84:92-101.
21. Armen TA, Vandse R, Crestanello JA, Raman SV, Bickle KM, Nathan NS. Mechanisms of valve competency after mitral valve annuloplasty for ischaemic mitral regurgitation using the Geoform ring: insights from three-dimensional echocardiography. Eur J Echocardiogr. 2009;10:74-81.
22. De Bonis M, Lapenna E, Verzini a, et al. Recurrence of mitral regurgitation parallels the absence of left ventricular reverse remodeling after mitral repair in advanced dilated cardiomyopathy. Ann Thorac Surg. 2008;85:932-9.
23. Braun J, van de Veire NR, Klautz RJM, et al. Restrictive mitral annuloplasty cures ischemic mitral regurgitation and heart failure. Ann Thorac Surg. 2008;85:430-7.
24. Hung J, Papakostas L, Tahta SA. Mechanism of recurrent ischemic mitral regurgitation after annuloplasty. Continued LV remodeling as a moving target. Circulation. 2004;110:II-85 - II-90.
25. McGee EC, Gillinov AM, Blackstone EH, et al. Recurrent mitral regurgitation after annuloplasty for functional ischemic mitral regurgitation. J Thorac Cardiovasc Surg. 2004;128:916-24.
26. American College of Cardiology/American Heart Association Task Force on Practice Guidelines; Society of Cardiovascular Anesthesiologists; Society for Cardiovascular Angiography and Interventions; Society of Thoracic Surgeons, Bonow RO, Carabello BA, Kanu C, et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation 2006;114:e84-e231 (Erratum in: Circulation. 2007;115:e409).
27. Detaint D, Sundt TM, Nkomo VT, et al. Surgical correction of mitral regurgitation in the elderly: outcomes and recent improvements Circulation. 2006;114:265-72.
28. Enriquez-Sarano M, Schaff HV, Orszulak TA, Tajik AJ, Bailey KR, Frye RL. Valve repair improves the outcome of surgery for mitral regurgitation. Circulation. 1995;91:1022-8.
29. Grigioni F, Enriquez-Sarano M, Zehr KJ, Bailey KR, Tajik AJ. Ischemic mitral regurgitation: long-term outcome and prognostic implications with quantitative Doppler assessment. Circulation 2001;103:1759-64.
30. Menicanti L, Di Donato M, Frigiola A, et al. Ischemic mitral regurgitation: intraventricular papillary muscle imbrication without mitral ring during left ventricular restoration. J Thorac Cardiovasc Surg. 2002;123:1041-50.
31. Velazquez EJ, Lee KL, O'Connor CM, et al. The rationale and design of the Surgical Treatment for Ischemic Heart Failure (STICH) trial. J Thorac Cardiovasc Surg. 2007;134:1540-7.
32. David TE, Ivanov J, Armstrong S, Rakowski H. Late outcomes of mitral valve repair for floppy valves: implications for asymptomatic patients. J Thorac Cardiovasc Surg. 2003;125:1143-52.
33. Rosenhek R, Rader F, Klaar U, et al. Outcome of watchful waiting in asymptomatic severe mitral regurgitation. Circulation. 2006;113:2238-44.
34. Breithardt OA, Sinha AM, Schwammenthal E, et al. Acute effects of cardiac resynchronization therapy on functional mitral regurgitation in advanced systolic heart failure. J Am Coll Cardiol. 2003;41:765-70.
35. Alfieri O, Maisano F, De Bonis M, et al. The double-orifice technique in mitral valve repair: a simple solution for complex problems. J Thorac Cardiovasc Surg. 2001;122:674-81.
36. Feldman T, Wasserman HS, Herrmann HC, et al. Percutaneous mitral valve repair using the edge-to-edge technique: sixmonth results of the EVEREST phase I clinical trial. J Am Coll Cardiol. 2005;46:2134-40.
37. Kar S. Experience with the MitraClip therapy in the EVEREST II high-risk registry (abstr). Abstract Book Euro-PCR 2009.
38. Byrne MJ, Kaye DM, Mathis M, Reuter DG, Alferness CA, Power JM. Percutaneous mitral annular reduction provides continued benefit in an ovine model of dilated cardiomyopathy. Circulation. 2004;110:3088-92.